[Effect of glucocorticosteroid and cytotoxic therapy on the natural cytotoxicity in rheumatic diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000276:immunology
D003520:Cyclophosphamide; D008775:Methylprednisolone
Vliianie gliukokortikosteroidnoĭ i tsitotoksicheskoĭ terapii na estestvennuiu tsitotoksichnost' pri revmaticheskikh.